117 related articles for article (PubMed ID: 38639364)
21. Age-specific differences in association of glycosylated hemoglobin levels with the prevalence of cardiovascular diseases among nondiabetics: the National Health and Nutrition Examination Survey 2005-2018.
Fan R; Li S; Xue Z; Yang R; Lyu J; He H
BMC Cardiovasc Disord; 2024 Jun; 24(1):310. PubMed ID: 38898403
[TBL] [Abstract][Full Text] [Related]
22. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
[TBL] [Abstract][Full Text] [Related]
23. Relation between HbA
Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
Diabetes Metab; 2018 Nov; 44(5):415-423. PubMed ID: 29449147
[TBL] [Abstract][Full Text] [Related]
24. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
[TBL] [Abstract][Full Text] [Related]
25. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.
Wang H; Shara NM; Lee ET; Devereux R; Calhoun D; de Simone G; Umans JG; Howard BV
Diabetes Care; 2011 Sep; 34(9):1952-8. PubMed ID: 21788631
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
[TBL] [Abstract][Full Text] [Related]
28. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
[TBL] [Abstract][Full Text] [Related]
29. Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population.
Hernandez D; Espejo-Gil A; Bernal-Lopez MR; Mancera-Romero J; Baca-Osorio AJ; Tinahones FJ; Armas-Padron AM; Ruiz-Esteban P; Torres A; Gomez-Huelgas R
BMC Nephrol; 2013 Jul; 14():151. PubMed ID: 23865389
[TBL] [Abstract][Full Text] [Related]
30. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study.
Singer DE; Nathan DM; Anderson KM; Wilson PW; Evans JC
Diabetes; 1992 Feb; 41(2):202-8. PubMed ID: 1733810
[TBL] [Abstract][Full Text] [Related]
31. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes.
Braffett BH; Bebu I; El Ghormli L; Cowie CC; Sivitz WI; Pop-Busui R; Larkin ME; Gubitosi-Klug RA; Nathan DM; Lachin JM; Dagogo-Jack S;
JAMA Netw Open; 2022 Sep; 5(9):e2230710. PubMed ID: 36074461
[TBL] [Abstract][Full Text] [Related]
32. Hemoglobin A
Palta P; Huang ES; Kalyani RR; Golden SH; Yeh HC
Diabetes Care; 2017 Apr; 40(4):453-460. PubMed ID: 28223299
[TBL] [Abstract][Full Text] [Related]
33. The association between fasting plasma glucose and all-cause and cause-specific mortality by gender: The rural Chinese cohort study.
Liu L; Chen X; Liu Y; Sun X; Yin Z; Li H; Zhang M; Wang B; Ren Y; Zhao Y; Liu D; Zhou J; Liu X; Zhang D; Cheng C; Liu F; Zhou Q; Xu Q; Xiong Y; Liu J; You Z; Hong S; Wang C; Hu D
Diabetes Metab Res Rev; 2019 May; 35(4):e3129. PubMed ID: 30657630
[TBL] [Abstract][Full Text] [Related]
34. Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.
Cook CB; Hentz JG; Tsui C; Ziemer DC; Naylor DB; Miller WJ
Ethn Dis; 2006; 16(4):852-8. PubMed ID: 17061737
[TBL] [Abstract][Full Text] [Related]
35. Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans.
Kim HK; Lee JB; Kim SH; Jo MW; Kim EH; Hwang JY; Bae SJ; Jung CH; Lee WJ; Park JY; Park GM; Kim YH; Choe J
J Diabetes; 2016 Sep; 8(5):657-66. PubMed ID: 26355268
[TBL] [Abstract][Full Text] [Related]
36. Haemoglobin A1c even within non-diabetic level is a predictor of cardiovascular disease in a general Japanese population: the Hisayama Study.
Ikeda F; Doi Y; Ninomiya T; Hirakawa Y; Mukai N; Hata J; Shikata K; Yoshida D; Matsumoto T; Kitazono T; Kiyohara Y
Cardiovasc Diabetol; 2013 Nov; 12():164. PubMed ID: 24195452
[TBL] [Abstract][Full Text] [Related]
37. ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk.
Zhang H; Qin L; Sheng CS; Niu Y; Gu H; Lu S; Yang Z; Tian J; Su Q
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958299
[TBL] [Abstract][Full Text] [Related]
38. Hemoglobin A1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: The CACTI Study.
Horton WB; Snell-Bergeon JK
J Clin Endocrinol Metab; 2023 Jun; 108(7):e444-e449. PubMed ID: 36637994
[TBL] [Abstract][Full Text] [Related]
39. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study.
Wan EY; Fung CS; Fong DY; Lam CL
J Diabetes Complications; 2016; 30(7):1240-7. PubMed ID: 27318537
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.
Cavender MA; Scirica BM; Raz I; Steg PG; McGuire DK; Leiter LA; Hirshberg B; Davidson J; Cahn A; Mosenzon O; Im K; Braunwald E; Bhatt DL
Am J Med; 2016 Mar; 129(3):340.e1-8. PubMed ID: 26524706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
